Clinical Research Directory
Browse clinical research sites, groups, and studies.
Imaging Tau Deposition in the Brain of Elderly Subjects
Sponsor: University of Zurich
Summary
Cerebral accumulation of tau and beta-amyloid are major factors of Alzheimer's disease pathology. A novel Positron Emission Tomography (PET) tracer (18-F-AV-1451) now offers the ability to study tau protein deposition in vivo in subjects, in which information on cerebral amyloid deposition has already been gathered. This enables to study effects of tau deposition on neuronal integrity, their relation to effects of beta-amyloid deposition and how this contributes to cognitive impairment or well-being in the elderly.
Key Details
Gender
All
Age Range
50 Years - Any
Study Type
INTERVENTIONAL
Enrollment
141
Start Date
2016-11
Completion Date
2029-12
Last Updated
2023-11-09
Healthy Volunteers
Yes
Interventions
18F-AV-1451 (Tau-PET tracer)
Single i.v. administration of 18F-AV-1451 (Tau-PET tracer) and consecutive Positron-Emission-Tomography-Scan
Locations (1)
Institute for Regenerative Medicine (IREM)
Schlieren, Canton of Zurich, Switzerland